Debt-to-equity of Tonix Pharmaceuticals Holding Corp. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Tonix Pharmaceuticals Holding Corp. Debt-to-equity for the quarter ending 30 Sep 2025 was 11%, a 72% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Tonix Pharmaceuticals Holding Corp. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 11% -27% -72% 30 Sep 2025
Q2 2025 14% -19% -59% 30 Jun 2025
Q1 2025 19% -4.5% -19% 31 Mar 2025
Q4 2024 27% +8.5% +45% 31 Dec 2024
Q3 2024 38% +27% +244% 30 Sep 2024
Q2 2024 33% +24% +271% 30 Jun 2024
Q1 2024 24% +16% +219% 31 Mar 2024
Q4 2023 19% +11% +155% 31 Dec 2023
Q3 2023 11% +3.3% +43% 30 Sep 2023
Q2 2023 8.8% +0.98% +13% 30 Jun 2023
Q1 2023 7.5% +0.19% +2.6% 31 Mar 2023
Q4 2022 7.4% +0.95% +15% 31 Dec 2022
Q3 2022 7.7% +1.8% +30% 30 Sep 2022
Q2 2022 7.8% +1.7% +28% 30 Jun 2022
Q1 2022 7.3% +0.23% +3.2% 31 Mar 2022
Q4 2021 6.4% -3.4% -34% 31 Dec 2021
Q3 2021 5.9% -5.3% -47% 30 Sep 2021
Q2 2021 6.1% -8.4% -58% 30 Jun 2021
Q1 2021 7.1% -13% -64% 31 Mar 2021
Q4 2020 9.8% -14% -59% 31 Dec 2020
Q3 2020 11% -3.5% -24% 30 Sep 2020
Q2 2020 14% +0.61% +4.4% 30 Jun 2020
Q1 2020 20% +5.9% +43% 31 Mar 2020
Q4 2019 24% +10% +74% 31 Dec 2019
Q3 2019 15% +1.9% +15% 30 Sep 2019
Q2 2019 14% +3.7% +37% 30 Jun 2019
Q1 2019 14% +5.9% +76% 31 Mar 2019
Q4 2018 14% +6.8% +96% 31 Dec 2018
Q3 2018 13% +5.9% +85% 30 Sep 2018
Q2 2018 10% +2.3% +29% 30 Jun 2018
Q1 2018 7.8% -2.7% -26% 31 Mar 2018
Q4 2017 7% -5% -41% 31 Dec 2017
Q3 2017 7% -7.2% -51% 30 Sep 2017
Q2 2017 7.8% -5.6% -42% 30 Jun 2017
Q1 2017 10% -1.9% -16% 31 Mar 2017
Q4 2016 12% +1.7% +16% 31 Dec 2016
Q3 2016 14% +5.4% +62% 30 Sep 2016
Q2 2016 13% +5.1% +61% 30 Jun 2016
Q1 2016 12% +5.2% +71% 31 Mar 2016
Q4 2015 10% +3.4% +50% 31 Dec 2015
Q3 2015 8.8% +1.4% +19% 30 Sep 2015
Q2 2015 8.3% -0.47% -5.3% 30 Jun 2015
Q1 2015 7.2% -8.2% -53% 31 Mar 2015
Q4 2014 6.8% -77% -92% 31 Dec 2014
Q3 2014 7.4% -172% -96% 30 Sep 2014
Q2 2014 8.8% +248% 30 Jun 2014
Q1 2014 15% -1115% -99% 31 Mar 2014
Q4 2013 84% -860% -91% 31 Dec 2013
Q3 2013 179% +451% 30 Sep 2013
Q2 2013 -239% +77% +24% 30 Jun 2013
Q1 2013 1130% +1338% 31 Mar 2013
Q4 2012 944% 31 Dec 2012
Q3 2012 -272% 30 Sep 2012
Q2 2012 -316% 30 Jun 2012
Q1 2012 -208% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.